Most treatment options for cervical intraepithelial neoplasia 2/3 (CIN2/3) are either excisional or ablative, and require sequential visits to health care providers. Connie Trimble, M.D.discusses recent advancements in studies performed to assess the safety and efficacy of self-administered artesunate vaginal inserts in biopsy-confirmed cervical intraepithelial neoplasia patients.
Related Presenters
Professor of Gynecology and Obstetrics
Professor of Gynecology and Obstetrics Expertise: Cervical Cancer, Cervical Dysplasia, Gynecology and Obstetrics, Human Papillomavirus Infections Research Interests: Cervical Cancer; HPV; Cancer Vaccines; tumor immunology, tumor ...
Related Videos
